Clinical Trials Browser

Phase 4 × Papillomavirus Infections × Gynecologic × Clear all

Uterine Cervical Neoplasms, Infections, Papillomavirus Infections, Squamous Intraepithelial Lesions of the Cervix

NCT05266898 2025-04-18

AGO-Gard

Phase 4 Recruiting

250 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT05916911 2024-02-07

Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)

Phase 4 Unknown

120 enrolled

Gynecologic

Squamous Intraepithelial Lesions, Papillomavirus Infections

NCT05426148 2022-06-29

Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

Phase 4 Completed

540 enrolled

Gynecologic

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04910802 2021-09-16

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

Phase 4 Recruiting

150,000 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT01101750 2021-01-05

Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?

Phase 4 Completed

25 enrolled 6 charts

Gynecologic

Uterine Cervical Neoplasms, Warts, Papillomavirus Infections

NCT01031069 2020-07-21

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Phase 4 Completed

873 enrolled 34 charts

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00534638 2019-11-15

Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents

Phase 4 Completed

34,412 enrolled 21 charts

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT01021904 2009-11-30

Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China

Phase 4 Unknown

6,200 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

Clinical Trials

RIFT-HPV

AGO-Gard

Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)

Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents

Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China